CORRESP Filing
HCW Biologics Inc.
Date: May 9, 2025 · CIK: 0001828673 · Accession: 0000950170-25-068196
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-287136
Letter
May 9, 2025 VIA EDGAR AND E-MAIL Mr. Jason Drory Office of Life Sciences Division of Corporate Finance U.S. Securities and Exchange Commission 100 F. Street, N.E. Washington, DC 20549-7010 Re: HCW Biologics Inc. Registration Statement on Form S-1; Commission File No. 333-287136 Dear Mr. Drory: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, HCW Biologics Inc. (the “Company”) hereby requests that the effectiveness of the Company’s Registration Statement on Form S-1 (File No. 333-287136) be accelerated by the U.S. Securities and Exchange Commission to 5:00 p.m. Eastern Time on Tuesday, May 13, 2025, or as soon thereafter is practicable. The Company hereby authorizes James Groth of Clark Hill PLC to orally modify or withdraw this request for acceleration. Please contact Mr. Groth at (312) 701-6830 with any questions you may have concerning this request, and please notify him when this request for acceleration has been granted. Thank you for your courtesy and cooperation in this matter. Very truly yours, HCW BIOLOGICS INC. By: /s/ Hing C. Wong Hing C. Wong, Founder and CEO HCW Biologics acceleration request for S-1 May 2025
Show Raw Text
CORRESP 1 filename1.htm CORRESP May 9, 2025 VIA EDGAR AND E-MAIL Mr. Jason Drory Office of Life Sciences Division of Corporate Finance U.S. Securities and Exchange Commission 100 F. Street, N.E. Washington, DC 20549-7010 Re: HCW Biologics Inc. Registration Statement on Form S-1; Commission File No. 333-287136 Dear Mr. Drory: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, HCW Biologics Inc. (the “Company”) hereby requests that the effectiveness of the Company’s Registration Statement on Form S-1 (File No. 333-287136) be accelerated by the U.S. Securities and Exchange Commission to 5:00 p.m. Eastern Time on Tuesday, May 13, 2025, or as soon thereafter is practicable. The Company hereby authorizes James Groth of Clark Hill PLC to orally modify or withdraw this request for acceleration. Please contact Mr. Groth at (312) 701-6830 with any questions you may have concerning this request, and please notify him when this request for acceleration has been granted. Thank you for your courtesy and cooperation in this matter. Very truly yours, HCW BIOLOGICS INC. By: /s/ Hing C. Wong Hing C. Wong, Founder and CEO HCW Biologics acceleration request for S-1 May 2025